Industry Research Reports

Home > Reports > Medical Care > Computer-aided Detection (CAD) for Breast Cancer Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Computer-aided Detection (CAD) for Breast Cancer Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 107 Pages

Report ld: 2639190

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Computer-aided Detection (CAD) for Breast Cancer Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Computer-aided Detection (CAD) for Breast Cancer Screening include CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta and McKesson Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection (CAD) for Breast Cancer Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computer-aided Detection (CAD) for Breast Cancer Screening by region & country, by Type, and by Application.

The Computer-aided Detection (CAD) for Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection (CAD) for Breast Cancer Screening.

Market Segmentation

Report Metric
Details
Report Title
Computer-aided Detection (CAD) for Breast Cancer Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Computer-aided Detection (CAD) for Breast Cancer Screening Companies Covered
CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta, McKesson Corporation, Merge Healthcare (IBM Corporation), Neusoft Corporation, Qlarity Imaging, LLC, Siemens Healthineers AG
Global Computer-aided Detection (CAD) for Breast Cancer Screening Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Computer-aided Detection (CAD) for Breast Cancer Screening Market, Segment by Type
Mammography CAD

MRI CAD

PET/CT CAD

Ultrasound CAD
Global Computer-aided Detection (CAD) for Breast Cancer Screening Market, Segment by Application
Clinics

Hospital

Medical Examination Center

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Computer-aided Detection (CAD) for Breast Cancer Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Computer-aided Detection (CAD) for Breast Cancer Screening Product Introduction
    1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size Forecast
    1.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Trends & Drivers
        1.3.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industry Trends
        1.3.2 Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers & Opportunity
        1.3.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
        1.3.4 Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Players Revenue Ranking (2023)
    2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue by Company (2019-2024)
    2.3 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Product Offered
    2.5 Key Companies Time to Begin Mass Production of Computer-aided Detection (CAD) for Breast Cancer Screening
    2.6 Computer-aided Detection (CAD) for Breast Cancer Screening Market Competitive Analysis
        2.6.1 Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Mammography CAD
        3.1.2 MRI CAD
        3.1.3 PET/CT CAD
        3.1.4 Ultrasound CAD
    3.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type
        3.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (2019-2030)
        3.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Clinics
        4.1.2 Hospital
        4.1.3 Medical Examination Center
        4.1.4 Others
    4.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application
        4.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (2019-2030)
        4.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region
        5.1.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024)
        5.1.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030)
        5.1.4 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        5.2.2 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        5.3.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        5.4.2 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        5.5.2 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        5.6.2 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value
    6.3 United States
        6.3.1 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.3.2 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.4.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.5.2 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.6.2 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.7.2 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.8.2 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
        6.9.2 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 CureMetrix, Inc.
        7.1.1 CureMetrix, Inc. Profile
        7.1.2 CureMetrix, Inc. Main Business
        7.1.3 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.1.4 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.1.5 CureMetrix, Inc. Recent Developments
    7.2 FUJIFILM Corporation
        7.2.1 FUJIFILM Corporation Profile
        7.2.2 FUJIFILM Corporation Main Business
        7.2.3 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.2.4 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.2.5 FUJIFILM Corporation Recent Developments
    7.3 GE Healthcare
        7.3.1 GE Healthcare Profile
        7.3.2 GE Healthcare Main Business
        7.3.3 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.3.4 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.3.5 Hitachi, Ltd. Recent Developments
    7.4 Hitachi, Ltd.
        7.4.1 Hitachi, Ltd. Profile
        7.4.2 Hitachi, Ltd. Main Business
        7.4.3 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.4.4 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.4.5 Hitachi, Ltd. Recent Developments
    7.5 Hologic, Inc.
        7.5.1 Hologic, Inc. Profile
        7.5.2 Hologic, Inc. Main Business
        7.5.3 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.5.4 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.5.5 Hologic, Inc. Recent Developments
    7.6 iCAD Inc.
        7.6.1 iCAD Inc. Profile
        7.6.2 iCAD Inc. Main Business
        7.6.3 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.6.4 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.6.5 iCAD Inc. Recent Developments
    7.7 IMS Giotto SpA
        7.7.1 IMS Giotto SpA Profile
        7.7.2 IMS Giotto SpA Main Business
        7.7.3 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.7.4 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.7.5 IMS Giotto SpA Recent Developments
    7.8 Konica Minolta
        7.8.1 Konica Minolta Profile
        7.8.2 Konica Minolta Main Business
        7.8.3 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.8.4 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.8.5 Konica Minolta Recent Developments
    7.9 McKesson Corporation
        7.9.1 McKesson Corporation Profile
        7.9.2 McKesson Corporation Main Business
        7.9.3 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.9.4 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.9.5 McKesson Corporation Recent Developments
    7.10 Merge Healthcare (IBM Corporation)
        7.10.1 Merge Healthcare (IBM Corporation) Profile
        7.10.2 Merge Healthcare (IBM Corporation) Main Business
        7.10.3 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.10.4 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.10.5 Merge Healthcare (IBM Corporation) Recent Developments
    7.11 Neusoft Corporation
        7.11.1 Neusoft Corporation Profile
        7.11.2 Neusoft Corporation Main Business
        7.11.3 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.11.4 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.11.5 Neusoft Corporation Recent Developments
    7.12 Qlarity Imaging, LLC
        7.12.1 Qlarity Imaging, LLC Profile
        7.12.2 Qlarity Imaging, LLC Main Business
        7.12.3 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.12.4 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.12.5 Qlarity Imaging, LLC Recent Developments
    7.13 Siemens Healthineers AG
        7.13.1 Siemens Healthineers AG Profile
        7.13.2 Siemens Healthineers AG Main Business
        7.13.3 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
        7.13.4 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
        7.13.5 Siemens Healthineers AG Recent Developments

 8 Industry Chain Analysis
    8.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industrial Chain
    8.2 Computer-aided Detection (CAD) for Breast Cancer Screening Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Computer-aided Detection (CAD) for Breast Cancer Screening Sales Model
        8.5.2 Sales Channel
        8.5.3 Computer-aided Detection (CAD) for Breast Cancer Screening Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Computer-aided Detection (CAD) for Breast Cancer Screening Market Trends
    Table 2. Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers & Opportunity
    Table 3. Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
    Table 4. Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
    Table 5. Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Product Type
    Table 9. Key Companies Time to Begin Mass Production of Computer-aided Detection (CAD) for Breast Cancer Screening
    Table 10. Global Computer-aided Detection (CAD) for Breast Cancer Screening Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024) & (%)
    Table 27. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2025-2030) & (US$ Million)
    Table 31. CureMetrix, Inc. Basic Information List
    Table 32. CureMetrix, Inc. Description and Business Overview
    Table 33. CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of CureMetrix, Inc. (2019-2024)
    Table 35. CureMetrix, Inc. Recent Developments
    Table 36. FUJIFILM Corporation Basic Information List
    Table 37. FUJIFILM Corporation Description and Business Overview
    Table 38. FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of FUJIFILM Corporation (2019-2024)
    Table 40. FUJIFILM Corporation Recent Developments
    Table 41. GE Healthcare Basic Information List
    Table 42. GE Healthcare Description and Business Overview
    Table 43. GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of GE Healthcare (2019-2024)
    Table 45. GE Healthcare Recent Developments
    Table 46. Hitachi, Ltd. Basic Information List
    Table 47. Hitachi, Ltd. Description and Business Overview
    Table 48. Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Hitachi, Ltd. (2019-2024)
    Table 50. Hitachi, Ltd. Recent Developments
    Table 51. Hologic, Inc. Basic Information List
    Table 52. Hologic, Inc. Description and Business Overview
    Table 53. Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Hologic, Inc. (2019-2024)
    Table 55. Hologic, Inc. Recent Developments
    Table 56. iCAD Inc. Basic Information List
    Table 57. iCAD Inc. Description and Business Overview
    Table 58. iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of iCAD Inc. (2019-2024)
    Table 60. iCAD Inc. Recent Developments
    Table 61. IMS Giotto SpA Basic Information List
    Table 62. IMS Giotto SpA Description and Business Overview
    Table 63. IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of IMS Giotto SpA (2019-2024)
    Table 65. IMS Giotto SpA Recent Developments
    Table 66. Konica Minolta Basic Information List
    Table 67. Konica Minolta Description and Business Overview
    Table 68. Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Konica Minolta (2019-2024)
    Table 70. Konica Minolta Recent Developments
    Table 71. McKesson Corporation Basic Information List
    Table 72. McKesson Corporation Description and Business Overview
    Table 73. McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of McKesson Corporation (2019-2024)
    Table 75. McKesson Corporation Recent Developments
    Table 76. Merge Healthcare (IBM Corporation) Basic Information List
    Table 77. Merge Healthcare (IBM Corporation) Description and Business Overview
    Table 78. Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Merge Healthcare (IBM Corporation) (2019-2024)
    Table 80. Merge Healthcare (IBM Corporation) Recent Developments
    Table 81. Neusoft Corporation Basic Information List
    Table 82. Neusoft Corporation Description and Business Overview
    Table 83. Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Neusoft Corporation (2019-2024)
    Table 85. Neusoft Corporation Recent Developments
    Table 86. Qlarity Imaging, LLC Basic Information List
    Table 87. Qlarity Imaging, LLC Description and Business Overview
    Table 88. Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Qlarity Imaging, LLC (2019-2024)
    Table 90. Qlarity Imaging, LLC Recent Developments
    Table 91. Siemens Healthineers AG Basic Information List
    Table 92. Siemens Healthineers AG Description and Business Overview
    Table 93. Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Siemens Healthineers AG (2019-2024)
    Table 95. Siemens Healthineers AG Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Computer-aided Detection (CAD) for Breast Cancer Screening Downstream Customers
    Table 99. Computer-aided Detection (CAD) for Breast Cancer Screening Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Computer-aided Detection (CAD) for Breast Cancer Screening Product Picture
    Figure 2. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 4. Computer-aided Detection (CAD) for Breast Cancer Screening Report Years Considered
    Figure 5. Global Computer-aided Detection (CAD) for Breast Cancer Screening Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2023
    Figure 7. Computer-aided Detection (CAD) for Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Mammography CAD Picture
    Figure 9. MRI CAD Picture
    Figure 10. PET/CT CAD Picture
    Figure 11. Ultrasound CAD Picture
    Figure 12. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Clinics
    Figure 15. Product Picture of Hospital
    Figure 16. Product Picture of Medical Examination Center
    Figure 17. Product Picture of Others
    Figure 18. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (%), (2019-2030)
    Figure 31. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
    Figure 52. Computer-aided Detection (CAD) for Breast Cancer Screening Industrial Chain
    Figure 53. Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

The global market for Computer-aided Detection (CAD) for Breast Cancer Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Computer-aided Detection (CAD) for Breast Cancer Screening include CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta and McKesson Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection (CAD) for Breast Cancer Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computer-aided Detection (CAD) for Breast Cancer Screening by region & country, by Type, and by Application.

The Computer-aided Detection (CAD) for Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection (CAD) for Breast Cancer Screening.

Market Segmentation